FDA Inspection 767584 — Society Hill Reproductive Medicine

Society Hill Reproductive Medicine — FEI 3008806154

The FDA completed an inspection of Society Hill Reproductive Medicine on Feb 13, 2012 in Philadelphia, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 13, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Philadelphia, PA (United States)

Citations

IDCFRDescription
1222121 CFR 1271.47(a)Procedures for all other requirements
1223121 CFR 1271.50(b)(1)Donor screening standards